| OBJECTIVES | Compare efficacy of a combined approach with intravenous t-PA+endovascular therapy (EVT) vs intravenous t-PA alone. |
| STUDY | Phase 3, international, multicenter, randomized, open-label clinical trial with blinded outcome. |
| POPULATION | Stroke within 3 hours after symptom onset receiving intravenous t-PA, NIHSS>10 or NIHSS 8 or 9 with M1 occlusion. |
| ENDPOINTS | 90 days mRS ≤2. |